| Transparency and accountability. | |
| | |
MedLine Citation:
|
PMID: 20734350 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
EMBO Molecular Medicine is enriched by a number of innovative policies designed to enhance the editorial process: peer review process files, de-emphasis of confidential referee comments and cross-refereeing. |
| | |
Authors:
|
Bernd Pulverer |
Publication Detail:
|
Type: Editorial |
Journal Detail:
|
Title: EMBO molecular medicine Volume: 2 ISSN: 1757-4684 ISO Abbreviation: EMBO Mol Med Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-07 Completed Date: 2011-01-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101487380 Medline TA: EMBO Mol Med Country: England |
Other Details:
|
Languages: eng Pagination: 329-30 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Editorial Policies Peer Review, Research* Social Responsibility* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fetal spinal anomalies in a first-trimester sonographic screening program for aneuploidy.
Next Document: Quantitative analysis of costunolide and dehydrocostuslactone in rat plasma by ultraperformance liqu...